首页> 外国专利> MONOCLONAL ANTIBODY REACTIVE WITH HUMAN-ORIGIN CETP AND METHOD OF QUANTIFYING HUMAN-ORIGIN CETP

MONOCLONAL ANTIBODY REACTIVE WITH HUMAN-ORIGIN CETP AND METHOD OF QUANTIFYING HUMAN-ORIGIN CETP

机译:人源CETP的单克隆抗体反应物及人源CETP的定量方法

摘要

A monoclonal antiboy that has a highly specific avidity with human-origin CETP (CETP inhibitory activity) and that is useful as a reagent for quantifying and purifying human-origin CETP and as a preventive or remedy for hyperlipemia and arteriosclerosis; and methods of quantifying and purifying human-origin CETP. The antibody permits the human-origin CETP contained in a sample to be quantified readily with a high sensitivity without the necessity for treating the sample with heat or surfactants. As the antibody has such a high CETP inhibitory activity, it is useful as medicines for treating or preventing, various diseases such as hyperlipemia, hyper-high-density-lipoproteinemia, hypercholesterolemia, and arteriosclerosis.
机译:具有对人源性CETP的高度特异性亲合力(CETP抑制活性)的单克隆抗男孩药物,可用作定量和纯化人源性CETP的试剂以及对高脂血症和动脉硬化的预防或治疗药物;以及定量和纯化人源CETP的方法。该抗体允许以高灵敏度容易地定量样品中包含的人源CETP,而无需通过加热或表面活性剂处理样品。由于该抗体具有如此高的CETP抑制活性,因此可用作治疗或预防各种疾病的药物,例如高脂血症,超高密度脂蛋白血症,高胆固醇血症和动脉硬化。

著录项

  • 公开/公告号EP0825259A4

    专利类型

  • 公开/公告日2001-04-25

    原文格式PDF

  • 申请/专利权人 JAPAN TOBACCO INC.;

    申请/专利号EP19960912292

  • 申请日1996-05-01

  • 分类号C12N15/02;C12N5/12;C12P21/08;C07K16/18;C07K16/46;C07K17/00;A61K39/395;G01N33/577;

  • 国家 EP

  • 入库时间 2022-08-22 01:16:51

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号